Summary
The pressor effect of intravenous tyramine (TYR) and noradrenaline (NA) has been evaluated, respectively, in 157 tests in 19 healthy unmedicated subjects, and in 202 tests in 24 similar subjects, all of whom took part in ≥3 test sessions.
The pressor dose (PD) that raised systolic blood pressure by 30 mm Hg (PD30) ranged from 2 to 8 mg for TYR, and from 3.5 to 17 μg · min−1 for NA. Coefficients of variation ranged from 3 to 47% and from 6 to 38% for TYR and NA, respectively, in the intra-subject comparison. The average inter-subject variation in the TYR PD30 was 22% for 8 females and 30% for 11 males; the corresponding variation in the NA PD30 was 27% (8 females) and 26% (16 males).
While the average PD30 for NA was similar for males (10.8 μg/min) and females (10.9 μg/min), a sex-related difference was found for the PD30 of i.v. TRY: 4.4 mg for 11 males and 3.8 mg for 8 females.
Additional results from volunteers who took part in fewer than 3 pressor test sessions supported this observation; PD30 of TYR 4.6 mg in 34 males vs 3.5 mg in 21 females.
The large intra- and inter-subject variations in the i.v. TYR and NA pressor test results, and the sex difference in the systolic blood pressure response to i.v. TYR, should be considered in assessing the number and gender of subjects required in studies intended to show “significant” differences in the blood pressure response in amine pressor tests.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bieck PR, Antonin KH (1982) Monoamine oxidase inhibition by tranylcyrpomine: Assessment in human volunteers. Eur J Clin Pharmacol 22: 301–308
Bieck PR, Antonin KH, Jedrychowski M (1983) Monoamino oxidase inhibition in healthy volunteers by CGP 11305 A, a new specific inhibitor of MAO-A. Mod Probl Pharmacopsychiat 19: 53–62
Bieck PR, Firkusny L, Schick C, Antonin KH, Nilsson E, Schulz R, Schwenk M, Wollmann H (1989) Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers. Clin Pharmacol Ther 45: 260–269
Blackwell B, Marley E, Price J, Taylor D (1967) Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs. Br J Psychiat 113: 349–365
Ghose K, Gifford LA, Turner P, Leighton M (1976) Studies of the interaction of desmethylimipramine with tyramine in man after a single oral dose, and its correlation with the plasma concentration. Br J Clin Pharmacol 3: 334–337
Ghose K (1977) Studies on the interaction between mianserin and noradrenaline in patients suffering from depressive illness. Br J Clin Pharmacol 4: 712–714
Ghose K (1980) Assessment of peripheral adrenergic activity and its interactions with drugs in man. Eur J Clin Pharmacol 17: 233–238
Ghose K (1984) Tyramine pressor test: implications and limitations. Meth Find Exptl Clin Pharmacol 6: 455–464
Pace DG, Reele SB, Rozik LM, Rogers-Phillips CA, Dabice JA, Givens SV (1988) Evaluation of methods of administering tyramine to raise systolic blood pressure. Clin Pharmacol Ther 44: 137–144
Pettinger WA, Soyangco FG, Oates JA (1968) Inhibition of monoamine oxidase in man by furazolidone. Clin Pharmacol Ther 9: 442–447
Pickar D, Cohen RM, Jimerson DC, Murphy DL (1981) Tyramine infusions and selective monoamine oxidase inhibitor treatment: I. Changes in pressor sensitivity. Psychopharmacology 74: 4–7
Simpson GM, White K (1984) Tyramine studies and the safety of MAOI drugs. J Clin Psychiat 45: 59–61
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reimann, I.W., Firkusny, L., Antonin, K.H. et al. Intravenous amine pressor tests in healthy volunteers. Eur J Clin Pharmacol 42, 137–141 (1992). https://doi.org/10.1007/BF00278472
Issue Date:
DOI: https://doi.org/10.1007/BF00278472